Acquisition Strategy Watson Pharmaceuticals has a history of strategic acquisitions such as Actavis and Allergan, positioning it as a key player in the pharmaceutical industry. Leveraging these acquisitions could lead to cross-selling opportunities and expanding product offerings.

Product Diversification With recent launches like the Hair System by Watsons and children's bottled water, Watson Pharmaceuticals is focusing on diversifying its product portfolio. Sales reps can capitalize on these new offerings to target different consumer segments and enhance revenue streams.

Partnership Opportunities Collaborations with companies like Identity Guard and Sherlock PR & Communications Ltd. showcase Watson's openness to partnerships. Exploring these collaborations further can lead to joint sales initiatives, tapping into each partner's customer base.

Expansion Initiatives The acquisition of Actavis for $63 billion and the recent expansion into the nutrient premix market highlight Watson's growth trajectory. Sales teams can explore the expansion into new markets and regions to drive revenue growth.

Competitive Analysis Analyzing key competitors like Glenmark Pharmaceuticals, Dr. Reddy's Laboratories, Cipla, Teva Pharmaceuticals, and Mylan can provide valuable insights into market positioning and potential areas for competitive advantage. Understanding the competitive landscape can help in tailoring sales strategies effectively.